Portal de investigación
A Multicenter, Double-Blind, Placebo-Controlled, Pivotal Phase III Study (PLEO-CMT) of a Fixed Combination of Baclofen, Naltrexone and Sorbitol (PXT3003) for Charcot-Marie-Tooth Disease Type 1A (CMT1A)
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Attarian, S
- Young, P
- van Damme, P
- Visser, M
- Thomas, F
- Roberts, M
- Foucquier, J
- Goedkoop, R
Grupos
Abstract
Abstract no disponible
Filiaciones
Filiaciones no disponibles
Campos de Estudio
Cita
Attarian,S,Young,P,Sevilla,T,van,P,Visser,M,Thomas,F,Roberts,M et al. A Multicenter, Double-Blind, Placebo-Controlled, Pivotal Phase III Study (PLEO-CMT) of a Fixed Combination of Baclofen, Naltrexone and Sorbitol (PXT3003) for Charcot-Marie-Tooth Disease Type 1A (CMT1A). 4th Congress of the European-Academy-of-Neurology (EAN). 2018. Lisbon. 111 RIVER ST, HOBOKEN 07030-5774, NJ:WILEY. 2018 p.p. 372-372.